Canaccord lowered the firm’s price target on iRhythm (IRTC) to $125 from $137 and keeps a Buy rating on the shares. The firm said they reported a solid Q3/24 and gave guidance in-line with expectations but they lowered their target to reflect both lower comp group multiples and slightly lower 2025 revenue due to the pushout of ZioMCT.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC: